Bristol-Myers Squibb

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Bristol-Myers Squibb 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About BMY

Bristol Myers Squibb Co. engages in the discovery, development, licensing, manufacture, marketing, distribution, and sale of biopharmaceutical products. It offers small molecules, products produced from biological processes called biologics, and chimeric antigen receptor (CAR-T) cell therapies. 

CEO
Christopher S. Boerner
CEOChristopher S. Boerner
Employees
32,500
Employees32,500
Headquarters
Princeton, New Jersey
HeadquartersPrinceton, New Jersey
Founded
1933
Founded1933
Employees
32,500
Employees32,500

BMY Key Statistics

Market cap
128.33B
Market cap128.33B
Price-Earnings ratio
13.77
Price-Earnings ratio13.77
Dividend yield
4.06%
Dividend yield4.06%
Average volume
10.42M
Average volume10.42M
High today
—
High today—
Low today
—
Low today—
Open price
$61.75
Open price$61.75
Volume
0.00
Volume0.00
52 Week high
$68.64
52 Week high$68.64
52 Week low
$45.27
52 Week low$45.27

Stock Snapshot

As of today, Bristol-Myers Squibb(BMY) shares are valued at $62.80. The company's market cap stands at 128.33B, with a P/E ratio of 13.77 and a dividend yield of 4.06%.

Bristol-Myers Squibb(BMY) stock opened on 2026-11-11 at $61.75. The price climbed to — and dipped to —.

The Bristol-Myers Squibb(BMY)'s current trading volume is 0, compared to an average daily volume of 10.42M.

During the past year, Bristol-Myers Squibb(BMY) stock moved between $45.27 at its lowest and $68.64 at its peak.

During the past year, Bristol-Myers Squibb(BMY) stock moved between $45.27 at its lowest and $68.64 at its peak.

BMY News

Simply Wall St 6h
What Bristol Myer Squibb Bulls Got Right - Simply Wall St

...

What Bristol Myer Squibb Bulls Got Right - Simply Wall St
Simply Wall St 4d
Has Bristol-Myers Squibb Moved Above Fair Value After A 41% Gain?

has delivered a 41.4% gain over the past three years, helped by fresh product launches and steady news flow, so the obvious question for you is whether that sha...

Has Bristol-Myers Squibb Moved Above Fair Value After A 41% Gain?
Seeking Alpha 5d
Bristol says long-term Camzyos data buoys treatment in children

Bristol says long-term Camzyos data buoys treatment in children Nov 06, 2026, 5:22 PM ET Bristol-Myers Squibb Company (BMY) Stock By : Jonathan Block, SA News E...

Bristol says long-term Camzyos data buoys treatment in children

Analyst ratings

59%

of 29 ratings
Buy
34.5%
Hold
58.6%
Sell
6.9%

More BMY News

24/7 Wall St. 5d
Bristol Myers Squibb Yields Over 4%. Can Its Dividend Survive 2027?

Investing Bristol Myers Squibb Yields Over 4%. Can Its Dividend Survive 2027? A blockbuster blood thinner is about to lose $1.5 billion to $2 billion in sales,...

Bristol Myers Squibb Yields Over 4%. Can Its Dividend Survive 2027?

People also own

Based on the portfolios of people who own BMY. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.